Twitter LinkedIn
    Tuesday, February 7
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals»Citizens advises Bionix Development Corporation on recapitalisation by Argosy Private Equity
    Deals

    Citizens advises Bionix Development Corporation on recapitalisation by Argosy Private Equity

    February 17, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Citizens M&A Advisory served as the exclusive M&A advisor to Bionix Development Corporation on its recapitalisation by Argosy Private Equity.

    Bionix, headquartered in Toledo, Ohio, is a leading developer of innovative healthcare products for single-use ear, nasal and wound care applications, among others. Co-founded in 1984 by Drew Milligan, PhD, and Jim Huttner, MD, PhD, Bionix produces its products in the United States and is trusted by physicians throughout the care continuum for developing premium products that set innovation, quality and performance standards. Argosy’s investment will allow Bionix’s co-founders and management team, led by President and CEO Chris Becker, to accelerate the company’s new product development and other organic and inorganic growth opportunities.

    “We are greatly appreciative of the Citizens M&A Advisory team’s guidance throughout this recapitalisation process, which has provided us with an ideal partner in Argosy for accelerating growth and maintaining Bionix’s proud legacy and culture in Toledo,” says Huttner, who will continue in his role as medical director and vice president of product development.

    “Bionix is an exceptional medical device company,” says Andrew Male, managing director in Citizens’ healthcare M&A practice. “We are excited for our clients to be able to accelerate the Company’s growth initiatives through this partnership with Argosy and further build upon the founders’ 30-year legacy of developing innovative, premium healthcare products.”

    Read more/Source: Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital deals PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    EQT Infrastructure acquires Madison Energy Investments

    December 22, 2022

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    Recent Rule Changes Spark New Wave of Private Equity Ownership in Pro Sports

    November 29, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    Comments are closed.

    Other Articles

    Blackstone, Starwood to Lend $2.5 Billion for Bourne Buyout

    February 16, 2021

    Blank-check boom prompts Michael Klein-backed SPAC to raise IPO size to $1 billion

    February 11, 2021

    CalPERS commits $15.2B to private markets

    November 14, 2022

    UK private equity activity soars to highest level in five years, says KPMG

    August 3, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?